Geographic atrophy from macular degeneration is a leading cause of untreatable blindness in the aging population. Oculogenex is developing a patented treatment that can repair the aged and damaged retina, reprogram it to a youthful state, and prevent vision loss from degeneration. This therapy can potentially last a lifetime and is delivered into the eye with an injection. Our technology can restore quality of life and protect the independence of millions at risk of blindness worldwide.
Connect with Oculogenex, Inc.